Life Science Leaders Discuss Strategies for Surviving the Financial Crisis at Yankee Public Relations...( 'Funding Biopharma: Strategies for Re...)

'Funding Biopharma: Strategies for Reaching Investors in a Financial Crisis' Draws Regional Biopharmaceutical Executives, Investment Leaders

BASKING RIDGE, N.J., June 18 /PRNewswire/ -- Biotech companies throughout the country are reeling from the economic recession with half of the industry's 370 small-cap funds slated to run out of cash before 2010, regional biopharmaceutical executives and investment market leaders concluded during a life sciences symposium presented by Yankee Public Relations. Panelists and attendees at "Funding Biopharma: Strategies for Reaching Investors in a Financial Crisis," emphasized the importance of intensifying investor relations efforts as biotechs continue to struggle with the market meltdown.

"I am seeing many situations in the private company and venture capital deal world with mistakes being made by companies pressed to the wall," said Jeffrey Nicholas, J.D., a Partner at Fox Rothschild in Princeton. "They don't necessarily take a good measure of their investors and realize what an asset their investor base can be. There is an intense public relations effort that should be deployed, in my view, in connection with any down round. It's no surprise to investors that a down round may be necessary, but how you communicate that message is very important. So the cautionary note is that companies need to put themselves in the position of the investor and realize how important it is to get the message out."

Yankee Public Relations President '/>"/>